-
-
-
-
-
-
-
Onconova Therapeutics (ONTX) Tops Q1 EPS by 2c
-
-
-
-
-
-
-
Onconova Therapeutics (ONTX) Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Q3, Provides Business Update
-
-
-
-
-
-
-
Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter Financial Results on August 11, 2022
-
-
-
-
-
-
-
Onconova Therapeutics Reports Full Year 2021 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2021 Financial Results on November 11, 2021
-
-
-
-
-
-
-
Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2021 Financial Results on May 17, 2021
-
-
-
-
-
-
-
Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
-
976,298 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All